Envista Holdings Corp(NVST)— Stock Profile, AI Score & Financials
Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Envista Holdings Corp (NVST) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NVST at 54.9/100 on a 32-signal composite quality model, placing it at rank #1,290 of 2,961 stocks — the top half of the AI-ranked universe. NVST scores in the top quartile across earnings quality (91.1). Areas of concern include institutional flow (30.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 48.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Envista Holdings Corp reports quarterly revenue of $730.5M, net income of $53.7M, an operating margin of 11.0%. Top institutional holders of NVST by reported 13-F value include BlackRock, ARIEL INVESTMENTS, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. NVST trades on the NYSE exchange and files with the SEC under CIK 1757073. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NVST daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Envista Holdings Corp directly from SEC EDGAR.
AI Quality Score
54.9/100
AI Rank
#1,290
Revenue
$730.5M
Net Income
$53.7M
Free Cash Flow
$104.3M
Operating Margin
11.0%
NVST key financials by period
Envista Holdings Corp reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$2.7B
$47.0M
8.0%
FY 2024
10-K
$2.5B
$-1.1B
-41.3%
FY 2023
10-K
$2.6B
$-100.2M
1.2%
FY 2022
10-K
$2.6B
$243.1M
12.4%
FY 2021
10-K
$2.5B
$340.5M
12.2%
FY 2020
10-K
$1.9B
$33.3M
2.3%
Institutions holding NVST
Institutional investors reporting a position in Envista Holdings Corp on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-08-05 — Q2 FY2026 (quarter ended July 3, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Envista Q2 revenue grew 7.1% to $730.5M with operating profit surging 73.4% to $80.3M, driven by 5.0% core sales growth and $12.6M in tariff refunds.
Biggest Revenue Drivers
Specialty Products & Technologies$471.0M+5.8% YoY
Dental implant systems, regenerative solutions, orthodontic brackets, and aligners grew from volume increase of 2.0% and price increase of 1.1%.
Equipment & Consumables$259.5M+9.5% YoY
Digital imaging systems, endodontic systems, restorative materials grew from volume increase of 5.5% and price increase of 3.0%.
Biggest Revenue Drivers
Total revenue: $730.5M+7.1% YoY
Specialty Products & Technologies$471.0M+5.8% YoY
Dental implant systems, regenerative solutions, orthodontic brackets, and aligners grew from volume increase of 2.0% and price increase of 1.1%.
Equipment & Consumables$259.5M+9.5% YoY
Digital imaging systems, endodontic systems, restorative materials grew from volume increase of 5.5% and price increase of 3.0%.
Largest Expense Items
Cost of sales$323.5M+3.6% YoY
Higher sales drove additional $13.5M in product costs; partially offset by $12.6M tariff refunds received.
Selling, general and administrative$296.3M+0.3% YoY
$7.2M increase in commercial growth initiatives offset by $3.2M property sale gain and $1.6M lower intangible amortization.
Research and development$30.4M+7.4% YoY
Higher investment in new product innovation to support future growth.
Margins: Gross margin expanded 150 basis points to 55.7% from 54.2%, driven by operational leverage on higher sales and tariff refund benefits. Operating margin improved significantly to 11.0% from 6.8%, reflecting gross profit gains and SG&A deleveraging.
Watch Items from the Filing
Largest customer represents 13% of total sales for Q2 2026, compared to 11% prior year, indicating modest customer concentration increase.
Tariff exposure remains; company received $12.6M refund in Q2 under Phase 1 IEEPA refund process for ~$30M paid tariffs, with timing and recoverability of remaining refunds uncertain.
Versah acquisition ($54.7M) in February 2026 integrated into Specialty Products segment; goodwill recognized of $20.9M, contributing to operating leverage gains.
Foreign currency headwind: 54.5% of Q2 sales from outside US; currency translation added 1.6% to reported growth but generated $6.8M other comprehensive loss.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
